These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19467686)

  • 21. Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya.
    van Eijk AM; Ayisi JG; ter Kuile FO; Slutsker L; Otieno JA; Misore AO; Odondi JO; Rosen DH; Kager PA; Steketee RW; Nahlen BL
    Trop Med Int Health; 2004 May; 9(5):630-7. PubMed ID: 15117309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda.
    Kiwuwa MS; Mufubenga P
    Malar J; 2008 Mar; 7():44. PubMed ID: 18312682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO; Bisaso RK; Byamugisha J; Obua C
    Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey.
    Ameyaw EK
    Malar J; 2022 Oct; 21(1):285. PubMed ID: 36207727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.
    Akinleye SO; Falade CO; Ajayi IO
    BMC Pregnancy Childbirth; 2009 Jul; 9():28. PubMed ID: 19589164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
    Arnaldo P; Cambe MI; Magaço A; Chicumbe S; Rovira-Vallbona E; Rosanas-Urgell A; Enosse SM
    PLoS One; 2019; 14(1):e0203740. PubMed ID: 30677039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda.
    Mbonye AK; Bygbjerg I; Magnussen P
    Health Policy; 2007 May; 81(2-3):228-41. PubMed ID: 16876286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin.
    Briand V; Denoeud L; Massougbodji A; Cot M
    J Infect Dis; 2008 Aug; 198(4):594-601. PubMed ID: 18598190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
    J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Trop Med Int Health; 2006 Jul; 11(7):992-1002. PubMed ID: 16827700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnographic study of factors influencing compliance to intermittent preventive treatment of malaria during pregnancy among Yao women in rural Malawi.
    Launiala A; Honkasalo ML
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):980-9. PubMed ID: 17658564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.